EpiBiologics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC (NCT07462377) | EpiBiologics | 2026-03-31 |
Track EpiBiologics automatically
Every clearance here is in the API, with alerts when new ones post.